{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:31:29Z","timestamp":1793766689098,"version":"4.6.1"},"reference-count":34,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Philanthropic contributions from Tim Ferriss, Matt Mullenweg, Blake Mycoskie, and Craig Nerenberg"},{"DOI":"10.13039\/100016230","name":"Steven and Alexandra Cohen Foundation","doi-asserted-by":"publisher","award":["Center for Psychedelic and Consciousness Research"],"award-info":[{"award-number":["Center for Psychedelic and Consciousness Research"]}],"id":[{"id":"10.13039\/100016230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Psilocybin is being studied for depression, but little is known about how it interacts with common antidepressants. Limited data suggest that psilocybin\u2019s effects may be diminished by serotonergic antidepressants acutely and even after a medication washout period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To learn the extent to which antidepressants may diminish the effects of psilocybin-containing mushrooms both concurrently and after discontinuation of antidepressants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Online retrospective survey of individuals with use of psilocybin mushrooms (1) with an antidepressant and\/or (2) within 2\u2009years of discontinuing an antidepressant. Participants who took mushrooms with an antidepressant and either took the same dose pre-antidepressant or took the same dose with other people not on antidepressant reported the strength of drug effects relative to their expectation. Participants who took mushrooms following discontinuation of an antidepressant also reported the presence of weakened effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In reports (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u2009611) of taking mushrooms with an antidepressant, probabilities [95% CI] of weaker than expected drug effects were 0.47 [0.41\u20130.54] (selective serotonergic reuptake inhibitors, SSRIs), 0.55 [0.44\u20130.67] (serotonin norepinephrine reuptake inhibitors, SNRIs) and 0.29 [0.2\u20130.39] (bupropion). Following SSRI\/SNRI discontinuation (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u20091,542 reports), the probability of reduced drug effects was not significantly different from the earliest post-discontinuation timepoint (within 1\u2009week) until 3\u20136\u2009months, probability\u2009=\u20090.3 [0.20\u20130.46],\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.001. A sensitivity analysis found that removing responses involving fluoxetine, which has an especially long half-life, did not significantly alter this result.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>SSRI\/SNRIs appear to weaken psilocybin drug effects relative to a non-serotonergic antidepressant. This dampening effect may last as long as 3\u2009months following antidepressant discontinuation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02698811231179910","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T01:55:32Z","timestamp":1686275732000},"page":"707-716","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":70,"title":["Attenuation of psilocybin mushroom effects during and after SSRI\/SNRI antidepressant use"],"prefix":"10.1177","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3567-1421","authenticated-orcid":false,"given":"Natalie","family":"Gukasyan","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Center for Psychedelic and Consciousness Research, Johns Hopkins School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5185-7854","authenticated-orcid":false,"given":"Roland R.","family":"Griffiths","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Center for Psychedelic and Consciousness Research, Johns Hopkins School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Yaden","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Center for Psychedelic and Consciousness Research, Johns Hopkins School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6814-0961","authenticated-orcid":false,"suffix":"II","given":"Denis G.","family":"Antoine","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6832-0639","authenticated-orcid":false,"given":"Sandeep M.","family":"Nayak","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Center for Psychedelic and Consciousness Research, Johns Hopkins School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2487."},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0893-133X(95)00145-4"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-4328(96)00102-7."},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032994"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2108082."},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4771-x"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.3285"},{"key":"e_1_3_2_9_1","unstructured":"Fox J Weisberg S (2019) An R Companion to Applied Regression 3rd edn. Thousand Oaks CA: Sage. Available at: https:\/\/socialsciences.mcmaster.ca\/jfox\/Books\/Companion\/."},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2106356."},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.11.016."},{"key":"e_1_3_2_12_1","first-page":"1637","volume-title":"New England Journal of Medicine","author":"Goodwin GM","year":"2022","unstructured":"Goodwin GM, Aaronson ST, Alvarez O, et al. (2022) Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. New England Journal of Medicine 387(18). Mass Medical Soc: 1637\u20131648."},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108094300."},{"key":"e_1_3_2_14_1","first-page":"306","article-title":"Blocking of LSD reaction by premedication with Niamid","volume":"7","author":"Grof S","year":"1965","unstructured":"Grof S, Dytrych Z (1965) Blocking of LSD reaction by premedication with Niamid. Activitas Nervosa Superior 7: 306.","journal-title":"Activitas Nervosa Superior"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211073759"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1017\/S2045796019000465."},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30032-X"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-019-0324-9."},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-021-05876-x."},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130051004."},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.1.78."},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1006\/nimg.2000.0619"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1524-2794."},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2003.11.002."},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.011478."},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-005-1772-5"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.149.6.843b"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2016.05.001"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00974."},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20220835"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06083-y"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811231154852"},{"key":"e_1_3_2_33_1","first-page":"33","article-title":"Three cases of acute serotonin syndrome due to psilocybin mushroom poisoning","volume":"29","author":"Suzuki K","year":"2016","unstructured":"Suzuki K (2016) [Three cases of acute serotonin syndrome due to psilocybin mushroom poisoning]. Chudoku Kenkyu: Chudoku Kenkyukai Jun Kikanshi = Jpn J Toxicol 29: 33\u201335.","journal-title":"Chudoku Kenkyu: Chudoku Kenkyukai Jun Kikanshi = Jpn J Toxicol"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199324030-00003."},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200102000-00010"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811231179910","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811231179910","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811231179910","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:11:25Z","timestamp":1777507885000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811231179910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1177\/02698811231179910"],"URL":"https:\/\/doi.org\/10.1177\/02698811231179910","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]}}}